600664 fundamentals
An in-depth look to HARBIN PHARMACEUTICAL GROUP CO.,LTD. operating, investing, and financing activities
600664 free cash flow for Q1 24 is -285.54 M CNY. For 2023, 600664 free cash flow was 863.72 M CNY and operating cash flow was 950.26 M CNY.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CNY
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM